Edwards LifesciencesEW
NYSE · USA · Segment 7 of 8 in the Medicine, pharma & life science value chain: Medtech & devices
American specialist in heart valves and structural heart treatment — including transcatheter aortic valves (TAVR).
Medtech & devices: Medical equipment and devices — from surgery and cardiology to robotics.
Key metrics
Market cap
$53.1B
Price
$91.92
Today
+0.6%
Return YTD
+7.1%
Return 1Y
+18.3%
P/E
48.5
P/S
8.4
P/B
5.1
Data as of 2026-07-10 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Transcatheter heart valves (TAVR)
- Surgical valves
- Structural heart
Competitors
Risks
- Competition in TAVR
- Growth slowdown
Same segment: Medtech & devices
See where Edwards Lifesciences sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →